UNIGE document Scientific Article
previous document  unige:24416  next document
add to browser collection

Lung cancer mortality risk among breast cancer patients treated with anti-estrogens

Soria, Jean-Charles
show hidden authors show all authors [1 - 10]
Published in Cancer. 2011, vol. 117, no. 6, p. 1288-95
Abstract The Women's Health Initiative randomized clinical trial reported that menopausal hormone therapy increases lung cancer mortality risk. If this is true, use of anti-estrogens should be associated with decreased lung cancer mortality risk. The authors compared lung cancer incidence and mortality among breast cancer patients with and without anti-estrogen therapy.
Keywords AdultAgedAged, 80 and overAntineoplastic Agents/therapeutic useBreast Neoplasms/complications/drug therapy/mortalityCarcinoma/complications/drug therapy/mortalityCohort StudiesEstrogen Receptor Modulators/therapeutic useFemaleHumansIncidenceLung Neoplasms/complications/drug therapy/etiology/mortalityMiddle AgedRegistriesRisk Factors
PMID: 21264820
Full text
Article (Published version) (119 Kb) - public document Free access
Research groups Epidémiologie des tumeurs (1017)
Groupe Bouchardy Magnin Christine (Registre genevois des tumeurs) (532)
(ISO format)
BOUCHARDY MAGNIN, Christine et al. Lung cancer mortality risk among breast cancer patients treated with anti-estrogens. In: Cancer, 2011, vol. 117, n° 6, p. 1288-95. doi: 10.1002/cncr.25638 https://archive-ouverte.unige.ch/unige:24416

544 hits



Deposited on : 2012-12-11

Export document
Format :
Citation style :